(Q39300015)

10 September 2017

The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer (English)

1 reference

10 September 2017

6

1 reference

10 September 2017

Rabia A Gilani

1

1 reference

10 September 2017

Armina A Kazi

2

1 reference

10 September 2017

Preeti Shah

3

1 reference

10 September 2017

Amanda J Schech

4

1 reference

10 September 2017

Saranya Chumsri

5

1 reference

10 September 2017

Anil K Jaiswal

7

1 reference

10 September 2017

Angela H Brodie

8

1 reference

10 September 2017

language of work or name

English

0 references

publication date

10 August 2012

1 reference

Breast Cancer Research and Treatment

10 September 2017

1 reference

10 September 2017

135

1 reference

10 September 2017

681-692

1 reference

10 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-012-2148-8

10 September 2017

0 references

cites work

Clinical strategies for rationale combinations of aromatase inhibitors with novel therapies for breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Stem cells: their role in breast cancer development and resistance to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Therapeutic implications of cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Stem cells in normal breast development and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Transcriptional upregulation of breast cancer resistance protein by 17beta-estradiol in ERalpha-positive MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Multipotential stem cells and 'side population' cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

EGFR regulates the side population in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Inhibition of epidermal growth factor receptor activity by two pyrimidopyrimidine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2148-8

10.1007/S10549-012-2148-8

21 January 2018

Identifiers

DOI

1 reference

release_zad6x2mcsvd7pnlcoseikk2se4

10 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zad6x2mcsvd7pnlcoseikk2se4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference